scispace - formally typeset
M

Mark Ashworth

Researcher at King's College London

Publications -  279
Citations -  6537

Mark Ashworth is an academic researcher from King's College London. The author has contributed to research in topics: Population & Medicine. The author has an hindex of 37, co-authored 245 publications receiving 5284 citations. Previous affiliations of Mark Ashworth include University of Cambridge.

Papers
More filters
Journal ArticleDOI

Benzodiazepines: addiction and abuse

TL;DR: The current understanding about benzodiazepines is summarized with the intention of supporting primary care in its changing role.
Proceedings ArticleDOI

In the wild pilot usability assessment of a connected health system for stroke self management

TL;DR: ConsULT as mentioned in this paper integrates data from commercial wellness sensors, electronic health records and clinical guidelines and enables users to monitor their vital signs to support self-monitoring and provision of tailored advice.
Journal ArticleDOI

Determinants of long‐term opioid prescribing in an urban population: A cross‐sectional study

TL;DR: The number of prescriptions for opioids in the UK has more than doubled between 1998 and 2016, and potential adverse health implications include dependency, falls and increased health expenditure.
Journal ArticleDOI

Hypertension and cardiovascular risk factor management in a multi-ethnic cohort of adults with CKD: a cross sectional study in general practice

TL;DR: In this paper, a cross-sectional survey using primary care electronic health records from 47/49 general practice clinicians in South London was conducted to assess hypertension and risk factor management, and determinants of systolic blood pressure control in individuals with CKD and hypertension.
Journal ArticleDOI

The Impact of Dementia on Diabetes Control: An Evaluation of HbA1c Trajectories and Care Outcomes in Linked Primary and Specialist Care Data.

TL;DR: In this paper , the authors characterize glycated hemoglobin A1c (HbA1c) trajectories, markers of diabetes-related management, health care utilization, and mortality in people with and without dementia and based on the extent of cognitive impairment at the time of dementia diagnosis.